Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China

Zhongge Wang; Ruirui Chen; Lizhen Zhang; Yarong Chen; Jing Li; Siyu Li; Lulu Xu; Yujia Hu; Yana Bai

doi:10.1097/CEJ.0000000000000863

Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China

Eur J Cancer Prev. 2023 Nov 13. doi: 10.1097/CEJ.0000000000000863. Online ahead of print.

Authors

Zhongge Wang¹, Ruirui Chen, Lizhen Zhang, Yarong Chen, Jing Li, Siyu Li, Lulu Xu, Yujia Hu, Yana Bai

Affiliation

¹ Department of Epidemiology and Health Statistics, School of Public Health, Lanzhou University, 199 Donggang West Street, Lanzhou, Gansu, China.

PMID: 38375832
DOI: 10.1097/CEJ.0000000000000863

Abstract

Objective: To evaluate the correlation between metabolic syndrome (MetS) and its components on the incidence of colorectal cancer (CRC) based on data from Jinchang Cohort.

Methods: This is a large prospective cohort study. Between 2011 and 2020, a total of 43 516 individuals from Jinchang Cohort were included for this study. Hazard ratios (HRs) with 95% confidence intervals (CIs) for CRC according to MetS were calculated with the Cox proportional hazard models. The restricted cubic spine models with four knots were conducted to fit the dose-response relationships.

Results: MetS was associated with increased risk of CRC (n = 141; HR: 1.64, 95% CI: 1.15-2.33) after adjusting for confounding factors (age, sex, education level, family history of CRC, smoking index and alcohol index). Participants with hyperglycemia had a significantly higher risk of developing incident CRC (HR: 1.70; 95% CI: 1.19-2.43). The positive association between MetS and CRC was observed in males (HR: 1.76; 95% CI: 1.17-2.63), but not in females (HR: 1.24; 95% CI: 0.59-2.64). Furthermore, linear dose-response relationship was found between fasting plasma glucose (FPG) and CRC risk in males (Poverall < 0.05, Pnon-linear = 0.35). When stratified by smoke and drink, MetS was found to increase the incidence of CRC only in the smoke (HR: 2.07, 95% CI: 1.35-3.18) and drink (HR: 2.93, 95% CI: 1.51-5.69) groups.

Conclusion: MetS was associated with a higher risk of CRC incidence. Hyperglycemia lended strong support to the role of MetS in new-onset CRC, especially in males. Other components of MetS were not found to be associated with increased risk of CRC.